Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00207168
Status:
COMPLETED
Last Update Posted:
2011-04-22
First Post:
2005-09-12
Brief Title:
To Assess Compliance With a Once-daily Regimen of Lamivudine Efavirenz and Didanosine
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
None
Primary Completion Date:
2006-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
September 19 2005
Study First Post Date:
2005-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-02-03
Disp First Submit QC Date:
February 3 2010
Disp First Post Date:
2010-02-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-04-08
Last Update Post Date:
2011-04-22
Last Update Post Date Type:
ESTIMATED